A pilot human study for evaluating effectiveness and safety of CKDGH_M030 on muscular function:randomized double blind placebo controlled trial
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0004453
- Lead Sponsor
- BiofoodCRO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 30
1. age : 50 to 85 years
2. time for 5 time chair rise test >11.19sec
3. calf size is less than 34cm in men and less than 33cm in women
Body Mass Index <18.5 or >30.
severe kidney disease or s-creatinine > 2.0mg/dl
AST or ALT : more than triple uppr reference level
HbA1C > 7.0% or hypoglycemia
Cancer diagnosed
uncontrolled hypertenson
acute myocardial infarct, unstable angina, severe heart failure, stroke, untreated atrial fibrillation
acute tuberculosis, pneumonia
severe COPD.
Psychosis, alcoholisms
Parkinson disease, stroke with paralysis
fractur in past 6 months
hemoglobin < 11.0 g/dL in men <10.0 g/dL in women, platelet count < 75,000/mm3
connective tissue disease needing corticosteroid
recent history of muscle acting herb or medicine
involved in other clincal trial
pregnancy or breastfeeding
hypersensitivity to Angelica
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5 time chair rise
- Secondary Outcome Measures
Name Time Method grip strength